Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Opal

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Critical Care Medicine|January 21, 2006
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safetyChristian J Wiedermann, Johannes N Hoffmann, Mathias Juers, et al.
Critical Care Medicine|April 12, 2003
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceMitchell M Levy, Mitchell P Fink, John C Marshall, et al.
Intensive Care Medicine|March 29, 2003
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceMitchell M Levy, Mitchell P Fink, John C Marshall, et al.
Scientific Reports|March 1, 2019
Novel Chitohexaose Analog Protects Young and Aged mice from CLP Induced Polymicrobial SepsisPragnya Das, Santosh K Panda, Beamon Agarwal, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2005
Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomalleiSteven P LaRosa, Steven M Opal, Barbara Utterback, et al.
The Journal of Infectious Diseases|March 16, 2013
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenesGirish Ramachandran, Mohan E Tulapurkar, Kristina M Harris, et al.
Intensive Care Medicine|January 29, 2017
Sepsis: frontiers in supportive care, organisation and researchAnders Perner, Andrew Rhodes, Bala Venkatesh, et al.
Journal of Immunology Research|June 27, 2015
NK and NKT Cell Depletion Alters the Outcome of Experimental Pneumococcal Pneumonia: Relationship with Regulation of Interferon-γ ProductionEirini Christaki, Evdoxia Diza, Evangelos J Giamarellos-Bourboulis, et al.
Vaccine|February 23, 2010
Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4Stephen H Gregory, Wilbur H Chen, Stephanie Mott, et al.
Critical Care Medicine|October 10, 2017
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma ConcentrationNuala J Meyer, John P Reilly, Brian J Anderson, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Critical Care Medicine|January 21, 2006
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safetyChristian J Wiedermann, Johannes N Hoffmann, Mathias Juers, et al.
Critical Care Medicine|April 12, 2003
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceMitchell M Levy, Mitchell P Fink, John C Marshall, et al.
Intensive Care Medicine|March 29, 2003
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceMitchell M Levy, Mitchell P Fink, John C Marshall, et al.
Scientific Reports|March 1, 2019
Novel Chitohexaose Analog Protects Young and Aged mice from CLP Induced Polymicrobial SepsisPragnya Das, Santosh K Panda, Beamon Agarwal, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2005
Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomalleiSteven P LaRosa, Steven M Opal, Barbara Utterback, et al.
The Journal of Infectious Diseases|March 16, 2013
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenesGirish Ramachandran, Mohan E Tulapurkar, Kristina M Harris, et al.
Intensive Care Medicine|January 29, 2017
Sepsis: frontiers in supportive care, organisation and researchAnders Perner, Andrew Rhodes, Bala Venkatesh, et al.
Journal of Immunology Research|June 27, 2015
NK and NKT Cell Depletion Alters the Outcome of Experimental Pneumococcal Pneumonia: Relationship with Regulation of Interferon-γ ProductionEirini Christaki, Evdoxia Diza, Evangelos J Giamarellos-Bourboulis, et al.
Vaccine|February 23, 2010
Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4Stephen H Gregory, Wilbur H Chen, Stephanie Mott, et al.
Critical Care Medicine|October 10, 2017
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma ConcentrationNuala J Meyer, John P Reilly, Brian J Anderson, et al.
Pageof 17